HIV in 2024: Progress, Problems & Prospects

Led by Jeffrey Lifson, M.D. and Mary Carrington, Ph.D., the "HIV in 2024: Progress, Problems, and Prospects" symposium marks the third installment in the prestigious Hood College – Frederick National Laboratory Life Sciences Symposium series. This latest collaborative event builds on the enduring legacy of the Hood College–National Cancer Institute Oncogene meetings, which has served as a cornerstone of the scientific community in Frederick for more than two decades.

NOTE:  As Dr. Anthony Fauci continues to make a full recovery from a bout of West Nile Fever virus, he regrets that he will be unable to deliver the originally scheduled Distinguished Opening Plenary Lecture to begin the Symposium. We send him our best wishes for a full recovery. We are honored that Dr. Clifford Lane, Director of Clinical Research and Clinical Director, National Institute of Allergy and Infectious Diseases, will deliver the Distinguished Opening Plenary Lecture. Dr. Lane, who was an active participant with Dr. Fauci in many of the key events and developments in HIV research and clinical care over the past several decades, will reflect on his experiences in HIV/AIDS in his lecture.

Reception, 5:30 p.m., Whitaker Campus Commons
Keynote, 7:30-8:30 p.m., Hodson Auditorium, Rosenstock Hall

Salim S. Abdool Karim, Ph.D.
Director, Centre for AIDS Program of Research, South Africa (CAPRISA); CAPRISA Professor of Global Health, Columbia University; Special Advisor to the Director-General of the World Health Organization; Pro Vice-Chancellor (Research), University of KwaZulu-Natal; Adjunct Professor of Medicine, Weill Medical College of Cornell University

Learn how your organization can support this symposium.

• AI in Cancer Research & Clinical Care: Turning Promise into Reality | September 2022
• The Imaging Science & Cancer Biology Symposium | June 2019